Prohibits health benefit plans from requiring step therapy prior to covering a prescription drug for the treatment of metastatic cancer and associated conditions.

Passed Legislature

This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.

Sponsor: Representative Grayber,, Senator Lieber, Representative Javadi,, Senator Frederick,
Last action: 2025-06-27
Official status: In House Committee
Effective date: Not listed

Plain English Breakdown

The plain English breakdown is still being put together. The official documents below are already here.

Bill History

2025-06-27 House
In committee upon adjournment.
2025-02-11 House
Public Hearing held.
2025-01-17 House
Referred to Behavioral Health and Health Care.
2025-01-13 House
First reading. Referred to Speaker's desk.

Official Summary Text

Digest: The Act bans health benefit plans from using step therapy for certain cancer drugs and treatments. (Flesch Readability Score: 63.6).
Prohibits health benefit plans from requiring step therapy prior to covering a prescription drug for the treatment of metastatic cancer and associated conditions.
Relating to: Relating to step therapy for metastatic cancer treatment.
Current location: In House Committee